These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 728887

  • 1. Therapeutic consequences of antitumour drug interactions: methotrexate and 5-fluorouracil in the chemotherapy of C3H mice with transplanted mammary adenocarcinoma.
    Brown I, Ward HW.
    Cancer Lett; 1978 Nov; 5(5):291-7. PubMed ID: 728887
    [Abstract] [Full Text] [Related]

  • 2. Effect of sequence of administration of methotrexate, leucovorin, and 5-fluorouracil on mammary tumor growth and survival in syngeneic C3H mice.
    Heppner GH, Calabresi P.
    Cancer Res; 1977 Dec; 37(12):4580-3. PubMed ID: 303542
    [Abstract] [Full Text] [Related]

  • 3. Adjuvant postoperative chemotherapy with 5-fluorouracil and methotrexate: effect of schedule of administration on metastasis of 13762 mammary adenocarcinoma.
    Lee YT, Khwaja TA.
    J Surg Oncol; 1977 Dec; 9(5):469-79. PubMed ID: 592846
    [Abstract] [Full Text] [Related]

  • 4. The effect of methotrexate on spontaneous mammary adenocarcinomata in female C3H mice.
    Shewell J.
    Br J Cancer; 1976 Feb; 33(2):210-6. PubMed ID: 1083245
    [Abstract] [Full Text] [Related]

  • 5. Levels of viral glycoprotein reflect enhanced effectiveness of combined drug treatments.
    Ritzi EM, Pyo S.
    Life Sci; 1994 Feb; 54(13):887-99. PubMed ID: 8139377
    [Abstract] [Full Text] [Related]

  • 6. Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor.
    Heppner GH, Dexter DL, DeNucci T, Miller FR, Calabresi P.
    Cancer Res; 1978 Nov; 38(11 Pt 1):3758-63. PubMed ID: 698935
    [Abstract] [Full Text] [Related]

  • 7. Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ.
    Grau C, Overgaard J.
    Cancer Chemother Pharmacol; 1992 Nov; 30(4):277-80. PubMed ID: 1643695
    [Abstract] [Full Text] [Related]

  • 8. Effect of methylprednisolone on cell proliferation in C3H/HeJ spontaneous mammary tumors.
    Braunschweiger PG, Stragand JJ, Schiffer LM.
    Cancer Res; 1978 Dec; 38(12):4510-4. PubMed ID: 719635
    [No Abstract] [Full Text] [Related]

  • 9. Effects of combination drug therapy on the subcutaneous and pulmonary growth of a slow and a fast-growing C3H/He mammary carcinoma.
    Vaage J, Costanza ME.
    Cancer Res; 1979 Nov; 39(11):4466-71. PubMed ID: 498077
    [Abstract] [Full Text] [Related]

  • 10. The comparative toxicity and therapeutic efficacy of adriamycin and the adriamycin-DNA complex in the chemotherapy of C3H mice with transplanted mammary adenocarcinoma.
    Brown I, Ward HW.
    Cancer Lett; 1977 Mar; 2(4-5):227-32. PubMed ID: 45724
    [Abstract] [Full Text] [Related]

  • 11. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
    Schmid FA, Sirotnak FM, Otter GM, DeGraw JI.
    Cancer Treat Rep; 1987 Mar; 71(7-8):727-32. PubMed ID: 3607784
    [Abstract] [Full Text] [Related]

  • 12. Remissions of mammary adenocarcinoma in hypothyroid mice given 5-fluorouracil and chloroquine phosphate.
    Shoemaker JP, Dagher RK.
    J Natl Cancer Inst; 1979 Jun; 62(6):1575-8. PubMed ID: 286128
    [Abstract] [Full Text] [Related]

  • 13. Effects on metastases of drug therapy during developing and established tumor immunity.
    Vaage J, Costanza ME.
    Int J Cancer; 1983 Dec 15; 32(6):759-63. PubMed ID: 6654527
    [Abstract] [Full Text] [Related]

  • 14. Intratumor treatment of C3H mouse mammary carcinoma with 5-fluorouracil adsorbed on activated charcoal particles.
    Bonhomme L, Mathieu MC, Amdidouche D, Faure E, Guisteau D, Fredj G, Naveau S.
    Anticancer Drugs; 1992 Jun 15; 3(3):261-6. PubMed ID: 1525407
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of Bcl-x(L) promotes chemotherapy resistance of mammary tumors in a syngeneic mouse model.
    Liu R, Page C, Beidler DR, Wicha MS, Núñez G.
    Am J Pathol; 1999 Dec 15; 155(6):1861-7. PubMed ID: 10595916
    [Abstract] [Full Text] [Related]

  • 16. Schedule-dependent cytotoxicity of methotrexate and 5-fluorouracil in human colon and breast tumor cell lines.
    Benz C, Schoenberg M, Choti M, Cadman E.
    J Clin Invest; 1980 Nov 15; 66(5):1162-5. PubMed ID: 7430346
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of intermediate-dose methotrexate and high-dose 5-fluorouracil as sequential combination chemotherapy in refractory breast cancer and as primary therapy in metastatic adenocarcinoma of the colon.
    Tisman G, Wu SJ.
    Cancer Treat Rep; 1980 Nov 15; 64(8-9):829-35. PubMed ID: 7448820
    [Abstract] [Full Text] [Related]

  • 18. The selectivity of action of methotrexate in combination with 5-fluorouracil in xenografts of human colon adenocarcinomas.
    Houghton JA, Tice AJ, Houghton PJ.
    Mol Pharmacol; 1982 Nov 15; 22(3):771-8. PubMed ID: 7155134
    [Abstract] [Full Text] [Related]

  • 19. [Kinetics of the cell proliferation of murine mammary adenocarcinoma under the influence of methylcobalamine].
    Golenko OD, Arsenian FG, Miasishcheva NV, Sof'ina ZP.
    Biull Eksp Biol Med; 1980 Feb 15; 89(2):185-7. PubMed ID: 7370419
    [Abstract] [Full Text] [Related]

  • 20. Antigenicity of C 3 H mammary carcinoma in isogenetic hosts: preliminary studies.
    Bernard LJ, Allen M, Birchette C, Royal J, Walker M.
    J Natl Med Assoc; 1973 Mar 15; 65(2):108-10 passim. PubMed ID: 4570900
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.